The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the Division supports a global research portfolio on HIV/AIDS, its related co-infections, and co-morbidities. With the ultimate goal of creating an “AIDS-free Generation,” the Division continually develops and supports the research infrastructure and scientific expertise needed to enable innovative approaches aimed at: 1) halting the spread of HIV through effective and acceptable prevention strategies and a preventive vaccine; 2) treating and curing HIV infection; 3) establishing treatment and prevention strategies for the HIV co-infections and co-morbidities of greatest significance; and 4) partnering with scientific and community stakeholders to implement effective interventions.
Media Availability: Immune-Enhancing Treatment May Destabilize HIV Reservoirs—July 21, 2016
Vaginal Ring May Cut HIV Infection Risk if Used Consistently—July 18, 2016
HIV Therapy for Breastfeeding Mothers Can Virtually Eliminate Transmission to Babies—July 18, 2016
NIH Expands Investment in HIV Cure Research—July 13, 2016
Media Availability: HIV Vaccine Research Requires Unprecedented Path—July 12, 2016
Last Updated July 21, 2016